GEODE-II: Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Low-Dose Ribavirin QD in Patients with Genotype 1a Chronic Hepatitis C Virus Infection without Cirrhosis

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共2页
• 作者

  Poordad Fred; Sedghi Shahriar; Pockros Paul J.; Ravendhran Natarajan; Reindollar Robert; Lucey Michael R.; Epstein Michael S.; Bank Leslie; Bernstein David E.; Trinh Roger; Krishnan Preethi; Pilot-Matias Tami; Polepally Akshanth R.; Pothacamury Rajvineeth K.; Unnebrink Kristina; Martinez Marisol; Nelson David R.;

  展开▼
• 作者单位

  Univ Texas Hlth Sci Ctr San Antonio Texas Liver Inst San Antonio TX 78229 USA;

  Mercer Univ Sch Med Med &

  Surg Macon GA 31207 USA;

  Scripps Clin Div Gastroenterol Hepatol La Jolla CA 92037 USA;

  Digest Dis Associates Baltimore MD USA;

  Piedmont Healthcare Carolinas Ctr Liver Dis Statesville NC USA;

  Univ Wisconsin Sch Med &

  Publ Hlth Dept Med Div Gastroenterol Hepatol Madison WI USA;

  Digest Disorders Associates Anne Arundel Med Ctr Annapolis MD USA;

  Reg Clin Res Inc Endwell NY USA;

  Hofstra Northwell Sch Med Manhasset NY USA;

  AbbVie Inc N Chicago IL USA;

  AbbVie Inc N Chicago IL USA;

  AbbVie Inc N Chicago IL USA;

  AbbVie Inc N Chicago IL USA;

  AbbVie Inc N Chicago IL USA;

  AbbVie Deutschland GmbH &

  Co KG Ludwigshafen Germany;

  AbbVie Inc N Chicago IL USA;

  Univ Florida Dept Med Gainesvillle FL USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词